Technology & Telecommunication Services » Software | Medidata Solutions Inc.

Medidata Solutions Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
276,849.00
335,071.00
392,506.00
463,381.00
545,532.00
635,696
Cost of Goods Sold (COGS) incl. D&A
70,124.00
89,581.00
94,508.00
120,596.00
137,033.00
170,218
Gross Income
206,725.00
245,490.00
297,998.00
342,785.00
408,499.00
465,478
SG&A Expense
182,098.00
218,542.00
268,166.00
292,476.00
348,602.00
414,492
EBIT
24,627.00
26,948.00
-
50,309.00
59,897.00
50,986
Unusual Expense
239.00
5,784.00
-
-
4,451.00
331
Non Operating Income/Expense
636.00
1,096.00
664.00
89.00
73.00
7,241
Interest Expense
5,925.00
15,368.00
16,192.00
17,288.00
17,765.00
15,855
Pretax Income
18,382.00
6,514.00
15,775.00
37,314.00
52,227.00
50,138
Income Tax
1,721.00
422.00
2,608.00
8,331.00
7,847.00
1,783
Consolidated Net Income
16,661.00
6,092.00
13,167.00
28,983.00
44,380.00
51,921
Net Income
16,661.00
6,092.00
13,167.00
28,983.00
44,380.00
51,921
Net Income After Extraordinaries
16,661.00
6,092.00
13,167.00
28,983.00
44,380.00
51,921
Net Income Available to Common
16,661.00
6,092.00
13,167.00
28,983.00
44,380.00
51,921
EPS (Basic)
0.31
0.11
0.23
0.51
0.74
0.85
Basic Shares Outstanding
51,060.00
52,561.00
53,717.00
55,492.00
56,473.00
58,125
EPS (Diluted)
0.31
0.11
0.23
0.51
0.74
0.85
Diluted Shares Outstanding
54,118.00
55,247.00
56,540.00
57,249.00
59,765.00
61,162
EBITDA
31,563.00
37,383.00
40,654.00
65,658.00
83,950.00
86,031
Non-Operating Interest Income
555.00
1,814.00
2,799.00
4,382.00
5,717.00
7,435

About Medidata Solutions

View Profile
Address
350 Hudson Street
New York New York 10014
United States
Employees -
Website http://www.mdsol.com
Updated 07/08/2019
Medidata Solutions, Inc. provides cloud based solutions for life sciences for customer's clinical development processes including concept, conclusion, research optimization, and development investments. Its cloud-based technology including its unified platform, pioneering analytics, and clinical technology allows the development of new therapies pharmaceutical companies, biotech, and medical device firms, academic medical centers and contract research organizations around the world. It operates through the following geographical segments: United States, Japan, and Other.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.